Company news: SDI and Cegedim

Share this article:

SDI and Cegedim Strategic Data are partnering on a market research service that tracks selling activities in the oncology therapeutic market. The Oncology Selling Audit, a monthly service to launch in January, will “provide nationally projected measures of personal selling in the oncology market, including competitive corporate calls, details, messages, and promotional spending,” and will allow analysis by tumor type, staging, and modalities, the two market research firms said.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.